Latest filing published 12 Aug 2021 for COLLEGIUM PHARMACEUTICAL, INC, €22k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alison B. Fleming: trading record in brief
Alison B. Fleming (senior executive) discloses dealings in Collegium Pharmaceutical, Inc to SEC (Form 4). In total, 65 filings cover trades dated from 27 January 2017 to 10 August 2021.
Sales make up the whole of the open-market record (19 sales, €1.7M). The rest of the record consists of 30 share grants and 16 option exercises. Since January 2021: no purchases and 9 sales on the market.
The latest filing, published on 12 August 2021, reports a share grant of €22k in Collegium Pharmaceutical, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alison B. Fleming
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,386 shares@ US$19.03100.0% of flowCommon StockSEC:0001192482-21-000662:0
1 of 1 declaration
